Confidential Disclosure Agreement In Clinical Research Template for New Zealand
Generate a bespoke document
What is a Confidential Disclosure Agreement In Clinical Research?
The Confidential Disclosure Agreement In Clinical Research is essential for organizations conducting clinical research in New Zealand where sensitive information needs to be shared between multiple parties. This agreement is typically used when initiating clinical trials, collaborative research projects, or when sharing research methodologies and results. It ensures compliance with New Zealand's Privacy Act 2020, Health Information Privacy Code 2020, and relevant healthcare regulations. The document covers the handling of confidential information including but not limited to patient data, research protocols, trial results, proprietary methodologies, and intellectual property. It is particularly crucial in early-stage research discussions, partnership evaluations, and throughout the duration of clinical trials.
About the Confidential Disclosure Agreement In Clinical Research
A Confidential Disclosure Agreement In Clinical Research is a specialized legal contract designed to protect sensitive information exchanged between parties involved in medical research and clinical trials. When you're conducting clinical research in New Zealand, this agreement ensures that confidential data including patient information, research protocols, trial results, and proprietary methodologies remain protected throughout your collaborative efforts.
When do you need this document?
You need this agreement whenever you're sharing confidential information in clinical research contexts. This includes initial discussions between pharmaceutical companies and research organizations about potential collaborations, when universities partner with biotechnology companies for clinical trials, or when contract research organizations (CROs) access proprietary data from medical device manufacturers. The document is particularly crucial during early-stage research evaluations, partnership negotiations, and throughout the entire duration of multi-party clinical studies where sensitive information must be exchanged between research sites, laboratories, and funding organizations.
Key legal considerations
Your agreement must clearly define what constitutes confidential information, including patient data, research methodologies, trial protocols, interim results, and any intellectual property developed during the research. You should specify the permitted uses of confidential information, ensuring it's limited to the specific research project and authorized personnel only. The agreement must include robust data security requirements, outlining how information will be stored, transmitted, and destroyed. Consider including provisions for return or destruction of confidential information upon project completion, consequences for breaches, and specific obligations regarding third-party disclosures. You'll also need to address intellectual property rights, particularly regarding any discoveries or innovations arising from the shared information.
Legal requirements in New Zealand
Your Confidential Disclosure Agreement must comply with New Zealand's Privacy Act 2020, which governs the collection, use, and disclosure of personal information, including research participant data. The Health Information Privacy Code 2020 imposes additional obligations for handling health-related information in research contexts, requiring specific safeguards and consent procedures. Under the Medicines Act 1981, clinical trials must maintain strict confidentiality standards, and your agreement should reflect these regulatory requirements. The Contract and Commercial Law Act 2017 provides the framework for enforcing confidentiality obligations, so ensure your agreement includes clear breach remedies and dispute resolution mechanisms. You must also consider the Health and Disability Commissioner Act 1994, which establishes participant rights that may impact how confidential information can be used and disclosed in your research.
GOVERNING LAW
Applicable law
This Confidential Disclosure Agreement In Clinical Research is drafted to comply with New Zealand law. Key legislation includes:
Health Information Privacy Code 2020: Specific rules for handling health information, including requirements for collection, storage, and disclosure of health-related data in research contexts.
Medicines Act 1981: Regulates clinical trials and medical research in New Zealand, including requirements for confidentiality in clinical studies.
Contract and Commercial Law Act 2017: Provides the legal framework for creating and enforcing confidentiality agreements and other contractual obligations in New Zealand.
Health and Disability Commissioner Act 1994: Establishes rights of research participants and obligations regarding confidentiality in health research.
Patents Act 2013: Relevant for protecting intellectual property that may arise from clinical research and maintaining confidentiality during patent pending periods.
New Zealand Bill of Rights Act 1990: Ensures protection of fundamental rights, including privacy rights and medical choice rights that may impact clinical research agreements.
Explore 208,390+ legal templates
Explore 208,390+ legal templates
Genie's Security Promise
Genie is the safest place to draft. Here's how we prioritise your privacy and security.
Your data is private:
We do not train on your data; Genie's AI improves independently
All data stored on Genie is private to your organisation
Your documents are protected:
Your documents are protected by ultra-secure 256-bit encryption
We are ISO27001 certified, so your data is secure
Organizational security:
You retain IP ownership of your documents and their information
You have full control over your data and who gets to see it